{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T20:42:15Z","timestamp":1777927335691,"version":"3.51.4"},"reference-count":9,"publisher":"SAGE Publications","issue":"14","license":[{"start":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T00:00:00Z","timestamp":1603324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Int J STD AIDS"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:p>We present a case of a 53-year-old male living with well-controlled HIV who, as part of routine monitoring, was noted to have an unexpected decline in renal function. His antiretrovirals were switched accordingly. It subsequently transpired that he had recently started taking creatine supplements in order to build muscle mass. He underwent specialist renal review and further investigation with a chromium-labelled scan which revealed his renal function was, in fact, stable. He continues under renal and HIV follow-up. It is now more widely recognised that creatine can affect renal function, and result in difficulty in interpretation of traditional renal blood tests. However, the further investigations that may be undertaken in such settings and HIV treatment considerations are not as widely reported. This case serves as a reminder to ensure over-the-counter and herbal supplements are part of routine questioning in HIV clinics, and outlines the specialist investigations that may be undertaken in cases of apparent renal decline.<\/jats:p>","DOI":"10.1177\/0956462420958343","type":"journal-article","created":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T04:00:26Z","timestamp":1603339226000},"page":"1411-1413","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Elevated serum creatinine in the context of HIV \u2013 who is the culprit? Over-the-counter supplements vs. antiretrovirals"],"prefix":"10.1177","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0120-6508","authenticated-orcid":false,"given":"A","family":"Gill","sequence":"first","affiliation":[{"name":"Cobridge Community Health Centre, Midlands Partnership NHS Foundation Trust, Stoke-on-Trent, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KA","family":"Fernando","sequence":"additional","affiliation":[{"name":"Cobridge Community Health Centre, Midlands Partnership NHS Foundation Trust, Stoke-on-Trent, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2020,10,22]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","unstructured":"Williamson L New D. How the use of creatine supplements can elevate serum creatinine in the absence of underlying kidney pathology. BMJ Case Rep 2014; 2014: bcr2014204754.","DOI":"10.1136\/bcr-2014-204754"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.4103\/0971-4065.111840"},{"key":"e_1_3_2_4_2","unstructured":"Toffaletti JG. Clarifying the confusion of GFRs creatinine and cystatin C https:\/\/acutecaretesting.org\/en\/articles\/clarifying-the-confusion-of-gfrs-creatinine-and-cystatin-c. (2018 accessed 23 July 2020)."},{"key":"e_1_3_2_5_2","unstructured":"Blake GM Burniston M et\u00a0al. Guidelines for the measurement of glomerular filtration rate using plasma sampling. London: British Nuclear Medicine Society."},{"key":"e_1_3_2_6_2","unstructured":"Stewart C. Vitamins and minerals sales value in Great Britain 2009\u20132019 www.statista.com\/statistics\/521713\/otc-vitamins-and-minerals-sales-value-great-britain\/ (2020 accessed 23 July 2020)."},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.00500107"},{"key":"e_1_3_2_8_2","unstructured":"British HIV Association guidelines for the routine investigation and monitoring of adult HIV-1 positive individuals (2019 interim update). https:\/\/www.bhiva.org\/file\/DqZbRxfzlYtLg\/Monitoring-Guidelines.pdf (2019 accessed 23 July 2020)."},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2012080857"},{"key":"e_1_3_2_10_2","first-page":"434","article-title":"Renal effects of novel antiretroviral drugs","volume":"32","author":"Milburn J","year":"2017","unstructured":"Milburn J, Jones R, Levy JB. Renal effects of novel antiretroviral drugs. Nephrol Dial Transplant 2017; 32: 434\u2013439.","journal-title":"Nephrol Dial Transplant"}],"container-title":["International Journal of STD &amp; AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0956462420958343","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/0956462420958343","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0956462420958343","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T22:41:16Z","timestamp":1777675276000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0956462420958343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,22]]},"references-count":9,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["10.1177\/0956462420958343"],"URL":"https:\/\/doi.org\/10.1177\/0956462420958343","relation":{},"ISSN":["0956-4624","1758-1052"],"issn-type":[{"value":"0956-4624","type":"print"},{"value":"1758-1052","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,22]]}}}